Clinical pharmacology and toxicology of dichloroacetate

Environmental Health Perspectives

Volumn 106, Issue SUPPL. 4, 1998, Pages 989-994

  Stacpoole, Peter W ^a,b   Henderson, George N ^a   Yan, Zimeng ^a   James, Margaret O ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Chlorination; Dichloroacetate; Drug metabolism; Glyoxylate; Neuropathy; Oxalate; Pyruvate dehydrogenase

Indexed keywords

CARBON DIOXIDE; CHLOROACETIC ACID; DICHLOROACETIC ACID; GLUCOSE; GLYCINE; GLYCOLIC ACID; GLYOXYLIC ACID; GROUND WATER; INDUSTRIAL CHEMICAL; LACTIC ACID; OXALIC ACID; PYRUVATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CARDIOVASCULAR DISEASE; CELL METABOLISM; CHLORINATION; CONFERENCE PAPER; DOSE RESPONSE; DRUG METABOLISM; ENZYME ACTIVITY; HEALTH HAZARD; HUMAN; LACTIC ACIDOSIS; LIVER TOXICITY; METABOLIC DISORDER; NEOPLASM; NONHUMAN; OXIDATION; PRIORITY JOURNAL;

EID: 0031657390     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106s4989     Document Type: Conference Paper

References (18)

1. Miller JW, Uden PC. Characterization of nonvolatile aqueous chlorination products of humic substances. Environ Sci Technol 17:150-157 (1983).
2. Uden PCC, Miller JW. Chlorinated acids and chloral in drinking water. J Am Water Works Assoc 75:524-527 (1983).
3. Mughal FH. Chlorination of drinking water and cancer:a review. J Environ Pathol Toxicol Oncol 11:287-292 (1992).
4. Jolley RL. Basic issues in water chlorination:a chemical perspective. In:Water Chlorination:Chemistry, Environmental Impact and Health Effects. Vol 5. Chelsea, MI:Lewis Publishers, 1985; 19-38.
5. Stacpoole PW. The pharmacology of dichloroacetate. Metabolism 38:1124-1144 (1989).
6. Henderson GN, Yan Z, James MO, Davydova N, Stacpoole PW. Kinetics and metabolism of chloral hydrate in children:identification of dichloroacetate as a metabolite. Biochem Biophys Res Commun 235:695-698 (1997).
7. Stacpoole PW, Henderson, GN, Yan Z, Cornett R, James MO. Pharmacokinetics, metabolism and toxicology of dichloroacetate. Drug Metab Rev (in press).
8. Jackson VN, Halestrap AP. The kinetics, substrate, and inhibitor specificity of the monocarboxylate (lactate) transporter of rat liver cells determined using the fluorescent intracellular pH indicator, 2′,7′-bis(carboxyethyl)-5(6)-carboxyfluorescein. J Biol Chem 271:861-868 (1996).
9. Bersin RM, Stacpoole PW. Dichloroacetate as metabolic therapy for myocardial ischemia and failure. Am Heart J 134:841-855 (1997).
10. Chu P-I. Pharmacokinetics of Sodium Dichloroacetate. PhD dissertation. Gainesville, FL:University of Florida, 1987.
11. Yan Z, Henderson GN, James MO, Stacpoole PW. Determination of dichloroacetate and its metabolites in human plasma by gas chromatography-mass spectrometry. J Chromatography B703:75-84 (1997).
12. Curry SH, Lorenz A, Chu P-I, Limacher M, Stacpoole PW. Disposition and pharmacodynamics of dichloroacetate (DCA) and oxalate following oral DCA doses. Biopharm Drug Disp 12:375-390 (1991).
13. Stacpoole PW, Barnes CL, Hurbanis MD, Cannon SL, Kerr DS. Treatment of congenital lactic acidosis with dichloroacetate. Arch Dis Child 77:535-541 (1997).
14. Stacpoole PW, Harman EM, Curry SH, Baumgartner TG, Misbin RI. Treatment of patients with lactic acidosis with dichloroacetate. N Engl J Med 309:390-396 (1983).
15. Stacpoole P, Wright EC, Baumgartner TG, Misbin RI, Bersin RM, Buchalter S, Curry SH, Duncan C, Hackett R, Harman EM, et al. A controlled clinical trial of dichloroacetate treatment in patients with lactic acidosis. N Engl J Med 327:1564-1569 (1992).
16. Curry SH, Chu P-I, Baumgartner TG, Stacpoole PW. Plasma concentrations and metabolic effects of intravenous sodium dichloroacetate. Clin Pharmacol Ther 37:89-93 (1985).
17. Stacpoole PW. Unpublished observation.
18. Stacpoole PW, Moore GW, Kornhauser DM. Metabolic effects of dichloroacetate in patients with diabetes mellitus and hyperlipoproteinemia. N Engl J Med 298:526-530 (1978).